Ultra Nasdaq Biotechnology Proshares (BIB) 96.17

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra Nasdaq Biotechnology Proshares (BIB) 96.17 $BIB

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra Nasdaq Biotechnology ETF After 4.54% Gain
Comtex SmarTrend(R) - Tue Jul 14, 5:10PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $95.13 to a high of $99.84. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $95.56 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 96.17 (+4.02)

ProShares Ultra Nasdaq Biotechnology ETF Rises 1.36% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jul 06, 5:38PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $88.72 to a high of $93.56. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $93.18 on volume of 469,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 96.17 (+4.02)

10-Minute Guide to 10 Most Popular Leveraged ETFs - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jun 23, 9:00AM CDT
Here a handy guide to the 10 most popular leveraged ETFs for short-term investors seeking to ride out the bull run.
UYG: 77.80 (+0.65), QLD: 78.57 (+1.40), UPRO: 69.23 (+2.32), UCO: 28.65 (+0.87), BIB: 96.17 (+4.02), SSO: 66.44 (+1.52), UWTI: 1.59 (+0.06), NUGT: 3.46 (+0.13), FAS: 33.73 (+0.49), TQQQ: 118.01 (+3.08)

Two more triple-levered biotech ETFs launch
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 8:22AM CDT

BBP: 36.40 (+0.92), PBE: 59.84 (+1.32), BBC: 36.81 (+0.63), SBIO: 38.49 (+0.87), BIS: 26.39 (-1.21), HQL: 29.31 (+1.26), FBT: 126.60 (+2.75), BIB: 96.17 (+4.02), XBI: 257.50 (+5.72), BBH: 138.82 (+2.81), IBB: 381.84 (+8.26), LABU: 49.42 (+3.19), LABD: 28.19 (-2.18)

ProShares Ultra Nasdaq Biotechnology ETF Falls 2.35% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jun 09, 5:14PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $85.40 to a high of $88.48. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $85.73 on volume of 729,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 96.17 (+4.02)

Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Jun 09, 11:08AM CDT
A quick discussion of the ways investors can play the biotechnology sector with leverage.
BIS: 26.39 (-1.21), BIB: 96.17 (+4.02), LABU: 49.42 (+3.19), LABD: 28.19 (-2.18)

BUYINS.NET: PMC, ATHN, QNST, MLPI, PRI, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Jun 08, 12:08PM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of PharMerica Corp (NYSEMC), Athenahealth Inc (NASDAQ:ATHN), Quinstreet Inc (NASDAQ:QNST), E-TRACS ALERIAN INFRASTR (NYSE:MLPI), Primerica Inc (NYSERI), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
PRI: 44.82 (+0.83), PMC: 33.87 (-0.18), BIB: 96.17 (+4.02), MLPI: 34.05 (+0.84), QNST: 6.00 (-0.03), ATHN: 136.03 (-0.65)

BUYINS.NET: BIB, LYB, DPS Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri May 08, 7:17AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), LyondellBasell Industries NV (NYSE:LYB), Dr Pepper Snapple Group Inc (NYSEPS) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
DPS: 79.00 (+1.36), LYB: 92.04 (+2.19), BIB: 96.17 (+4.02)

Hidden Gems In This Market Cycle's Leading Theme
Cam Hui, CFA - Seeking Alpha - Fri May 08, 5:18AM CDT
Philosophical Economics wrote a terrific post yesterday about how the "Winner take all" economy is affecting companies and the competitive environment. He observed that net margins have been elevated in the last few years. Generally, when...
BIS: 26.39 (-1.21), BIB: 96.17 (+4.02), IBB: 381.84 (+8.26)

FDA to hold public meeting on off-label drug promotion
Seeking Alpha - at Seeking Alpha - Thu May 07, 10:13AM CDT

ABT: 50.93 (+0.24), BIB: 96.17 (+4.02), PFE: 35.24 (+0.90), IBB: 381.84 (+8.26), DRGS: 60.10 (-0.69), LLY: 85.51 (+1.36), BMY: 64.50 (+0.20), GSK: 41.68 (+0.08), JNJ: 99.12 (+0.84), BIS: 26.39 (-1.21), AZN: 32.86 (+0.15), MRK: 57.26 (+0.27), ABBV: 70.72 (+1.38), SNY: 53.58 (+0.25), IRY: 54.12 (+0.52), IXJ: 111.90 (+1.60), NVS: 102.70 (+1.16)

ProShares planning a split for 21 ETFs
Seeking Alpha - at Seeking Alpha - Mon May 04, 11:51AM CDT

UYG: 77.80 (+0.65), SCC: 42.70 (unch), ROM: 79.14 (+1.89), UCO: 28.65 (+0.87), SAA: 58.56 (+1.47), RXL: 77.13 (+2.60), BIB: 96.17 (+4.02), SSO: 66.44 (+1.52), UVXY: 27.36 (-4.79), RWM: 59.31 (-0.43), UMDD: 60.01 (+1.77), DDM: 66.12 (+1.30), QLD: 78.57 (+1.40), UPRO: 69.23 (+2.32), YCL: 52.20 (unch), BOIL: 44.08 (+0.59), UCD: 40.25 (-0.25), RXD: 46.87 (unch), CSM: 50.59 (+0.72), UDOW: 68.17 (+2.03), SRS: 50.21 (-0.28)

ProShares Announces ETF Share Splits
Business Wire - Fri May 01, 3:05PM CDT
ProShares, a premier provider of alternative ETFs, announced today forward and reverse share splits on 21 of its ETFs. The splits will not change the value of a shareholder's investment.
ROM: 79.14 (+1.89), UCO: 28.65 (+0.87), BIB: 96.17 (+4.02)

Biotechs continue slide
Seeking Alpha - at Seeking Alpha - Wed Apr 29, 11:42AM CDT

BIS: 26.39 (-1.21), BIB: 96.17 (+4.02), IBB: 381.84 (+8.26)

Look for Shares of ProShares Ultra Nasdaq Biotechnology ETF to Potentially Rebound after Yesterday's 8.25% Sell Off
Comtex SmarTrend(R) - Mon Apr 27, 5:06PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $161.49 to a high of $178.64. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $175.31 on volume of 1.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 96.17 (+4.02)

Drug makers getting visability over aggressive pricing practices
Seeking Alpha - at Seeking Alpha - Mon Apr 27, 10:19AM CDT

MNK: 123.44 (+0.36), BIS: 26.39 (-1.21), VRX: 258.32 (+1.02), BIB: 96.17 (+4.02), IBB: 381.84 (+8.26), DRGS: 60.10 (-0.69)

U.S. drug spending rose 13% in 2014
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 6:28AM CDT

BIS: 26.39 (-1.21), BIB: 96.17 (+4.02), IBB: 381.84 (+8.26), DRGS: 60.10 (-0.69), IXJ: 111.90 (+1.60), IRY: 54.12 (+0.52)

BUYINS.NET: DFJ, PTH, UNL, TQQQ, KW, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Apr 10, 6:59AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of WisdomTree Japan Smallcap Dividend Fund (NYSEFJ), PowerShares Dynamic Heathcare Sector Portfolio (NYSETH), United States 12 Month Natural Gas Fund LP (NYSE:UNL), ProShares Trust UltraPro QQQ ETF (NASDAQ:TQQQ), Kennedy Wilson Holdings Inc (NYSE:KW), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BIB: 96.17 (+4.02), PTH: 65.40 (+1.45), KW: 25.22 (-0.03), DFJ: 56.20 (+0.67), UNL: 12.80 (+0.12), TQQQ: 118.01 (+3.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 328

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 258

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 459

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 131

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 157

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 121

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 332

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 509

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 250

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading

Top 5 Most Recently Viewed Articles

Liberty Tire Recycling Raises Substantial Funds for Childhood Hunger

Updated Category News Views 47

Liberty Tire Recycling's Philanthropic Efforts Liberty Tire Recycling has impressively raised $87,805 to support Blessings in a Backpack, an organization dedicated to combating childhood hunger. This significant amount was a result of several engaging events, including a charity golf tournament and multiple packing sessions, where employees actively participated....

Continue Reading
Future of Surface Disinfectant Products and Market Growth

Updated Category News Views 184

Growth of the Surface Disinfectant Products Market The surface disinfectant products market is on a promising trajectory, forecasted to reach USD 65.7 billion by 2035, with a compound annual growth rate (CAGR) of 4.8% starting in 2025. This growth reflects a broader trend towards increased consciousness around hygiene and health safety, particularly in light of recent...

Continue Reading
Cryptocurrency Market Update: Bitcoin and Ethereum Trends

Updated Category News Views 226

Cryptocurrency Market Overview As of Tuesday morning, the cryptocurrency market is experiencing a decline, with Bitcoin's price falling to $113,000 amidst ongoing negotiations regarding a government shutdown in the U.S. This pivotal moment has left investors analyzing market movements closely. Key Cryptocurrency Prices The current prices for major cryptocurrencies are as...

Continue Reading
Market Positioning Insights and Risks: What Investors Should Know

Updated Category News Views 68

S&P 500 Positioning Risks Highlighted by Citi Recent analysis by Citi strategists reveals concerning trends in the S&P 500's positioning, now at levels not seen in the past three years. This significant rise in positioning makes the index noticeable among other markets, where investor conviction remains unsteady. Understanding Market Pullbacks Historical data emphasizes a...

Continue Reading
Galmed Pharmaceuticals Unveils Innovative Digital Asset Strategy

Updated Category News Views 126

Galmed Pharmaceuticals' Strategic Move into Digital Assets Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD), a clinical-stage biopharmaceutical company specializing in the treatment of various diseases, has embarked on an innovative journey that dives into digital asset management. This strategic decision aims to enhance capital efficiency and bolster shareholder value through...

Continue Reading